Ambu A/S
AMBBY
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.1B
Close$
$5.16
55.7% downside
Current Fair Value
55.7% downsideOvervalued by 55.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.10 Billion |
|---|---|
| Enterprise Value | $2.98 Billion |
| Dividend Yield | $0.06 (0.56%) |
| Earnings per Share | $2.15 |
| Beta | 1.43 |
| Outstanding Shares | 266,555,404 |
Return
| Return on Equity | 8.27% |
|---|---|
| Return on Assets | 6.56% |
| Return on Invested Capital | 10.53% |
Valuation & Multiples
| P/E Ratio | 38.14 |
|---|---|
| PEG | 142.16 |
| Price to Sales | 0.51 |
| Price to Book Ratio | 0.51 |
| Enterprise Value to Revenue | 0.48 |
| Enterprise Value to EBIT | 4.24 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 25, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$253.28 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Ambu A/S
5,384 employees
CEO: Britt Meelby Jensen Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Vi...